Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Progenitor Cell Mobilisation

Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study

Abstract

Mobilization of peripheral blood cell progenitor cells was investigated in 36 healthy sibling donors using three different split doses of glycosylated rhG-CSF (lenograstim). The donors were randomized into three groups: group 1 was given lenograstim at 8, group 2 at 11 and group 3 at 15 μg/kg/day in two split doses, subcutaneously for 4 and 5 days, respectively. Leukapheresis was performed on day 4 or 5 depending on the WBC and CD34+ cell count. We were able to demonstrate that there was a significant correlation between circulating CD34+cells on the day of harvest and CD34+ cells in the apheresis products in all three groups. The number of CD34+ cells pre-apheresis was inversely correlated with age in group 1 and group 2. However, in group 3, the number of CD34+ cells pre-apheresis did not correlate with age. There was also a difference between the number of progenitor cells mobilized in the three dose groups regarding the time of harvest. Apheresis was performed in groups 1 and 2 on day 5 of mobilization in order to obtain a sufficient number of stem cells for allogeneic transplantation. In contrast, with the split dose of 15 μg/kg/day, harvest could be routinely performed on day 4 of stimulation. We conclude that lenograstim given twice a day at doses of 8, 11 and 15 μg/kg/day provided different CD34+ cell yields in normal donors, in particular, with regard to the time of harvest. The number of CD34+cells pre-apheresis was not correlated with age in the group of donors mobilized with a split dose of 15 μg/kg/day, indicating that this dosage might also be suitable for older donors. Bone Marrow Transplantation (2000) 25, 371–376.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation Blood 1993 81: 1404–1407

    CAS  PubMed  Google Scholar 

  2. Russel NH, Hunter AE . Peripheral blood stem cells for allogeneic transplantation Bone Marrow Transplant 1994 13: 353–355

    Google Scholar 

  3. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 1995 85: 1655–1658

    CAS  PubMed  Google Scholar 

  4. Schmitz N, Bacigalupo A, Labopin M et al. on behalf of the European Group for Blood and Marrow Transplantation (EBMT)Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors Br J Haematol 1996 95: 715–723

    Article  CAS  PubMed  Google Scholar 

  5. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794–2800

    CAS  PubMed  Google Scholar 

  6. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1998 21: 995–1003

    Article  CAS  PubMed  Google Scholar 

  7. Russel NH, Hunter A, Roger S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation Lancet 1993 341: 1482–1483

    Article  Google Scholar 

  8. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte–macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation Blood 1995 85: 275–282

    CAS  PubMed  Google Scholar 

  9. Goldman J . Peripheral blood stem cells for allografting Blood 1995 85: 1413–1415

    CAS  PubMed  Google Scholar 

  10. Höglund M, Smedmyr B, Simonsson B et al. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF Bone Marrow Transplant 1996 18: 19–27

    PubMed  Google Scholar 

  11. Waller TF, Bertz H, Wenger MK et al. Mobilisation of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen Bone Marrow Transplant 1996 18: 279–283

    CAS  PubMed  Google Scholar 

  12. Höglund M, Smedmyr B, Bengtsson M et al. Mobilization of CD34 cells by glycosylated and nonglycosylated G-CSF in healthy volunteers – a comparative study Eur J Haematol 1997 59: 177–183

    Article  PubMed  Google Scholar 

  13. Anderlini P, Przepiorka D, Seong C et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim Transfusion 1997 37: 507–512

    Article  CAS  PubMed  Google Scholar 

  14. Kreissig C, Kirsch A, Serke S . Characterization and measurement of CD34 expressing hematopoietic cells J Chemother 1994 3: 263–289

    CAS  Google Scholar 

  15. Fauser AA, Messner HA . Granuloerythropoietic colonies in human bone marrow, peripheral blood and cord blood Blood 1978 52: 1243–1248

    CAS  PubMed  Google Scholar 

  16. Steel RGD, Torrie JH . Principles and Procedures of Statistics McGraw-Hill: New York 1960

    Google Scholar 

  17. Luider J, Brown C, Selinger S et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection and duration of leukapheresis J Hematother 1997 6: 575–580

    Article  CAS  PubMed  Google Scholar 

  18. Tanaka R, Matsudaira T, Aizawa J et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose effect relationship for filgrastim with the character of mobilized PBPC Br J Haematol 1996 92: 705–803

    Article  Google Scholar 

  19. Arbona C, Prosper F, Benet I et al. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation Bone Marrow Transplant 1998 22: 39–45

    Article  CAS  PubMed  Google Scholar 

  20. Weaver CH, Birch R, Greco FA et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim Br J Haematol 1998 100: 338–347

    Article  CAS  PubMed  Google Scholar 

  21. Dreger P, Haferlach T, Eckstein V et al. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft Br J Haematol 1994 87: 609–613

    Article  CAS  PubMed  Google Scholar 

  22. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464

    CAS  PubMed  Google Scholar 

  23. Grigg AP, Roberts AW, Raunow H et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilisation and collection of peripheral blood progenitor cells in normal volunteers Blood 1995 86: 4437–4445

    CAS  PubMed  Google Scholar 

  24. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after administration of recombinant human granulocyte colony stimulating factor Blood 1993 82: 1981–1984

    CAS  PubMed  Google Scholar 

  25. Geissler K, Peschel C, Niederwieser D et al. Potentiation of granulocyte colony stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3 Blood 1996 87: 2732–2739

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basara, N., Schmetzer, B., Blau, I. et al. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study. Bone Marrow Transplant 25, 371–376 (2000). https://doi.org/10.1038/sj.bmt.1702168

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702168

Keywords

This article is cited by

Search

Quick links